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ABSTRACT: The positron emission tomography imaging agents cis- and
trans-4-[18F]fluoro-L-proline are used for the detection of numerous
diseases such as pulmonary fibrosis and various carcinomas. These
imaging agents are typically prepared by nucleophilic fluorination of 4-
hydroxy-L-proline derivatives, with [18F]fluoride, followed by depro-
tection. Although effective radiofluorination reactions have been
developed, the overall radiosynthesis process is suboptimal due to
deprotection methods that are performed manually, require multiple
steps, or involve harsh conditions. Here we describe the development of
two synthetic routes that allow access to precursors, which undergo highly
selective radiofluorination reactions and rapid deprotection, under mild
acidic conditions. These methods were found to be compatible with
automation, avoiding manual handling of radioactive intermediates.
■ INTRODUCTION
α-Amino acids are the key building blocks of life, acting as
structural components of peptides and proteins.1 They also
play an important role in biochemical and physiological
processes, including energy metabolism, and in the formation
of neurotransmitters and hormones. Due to the varied and
important roles of α-amino acids in nature, their structural
analogues have often been used to study biological processes
and mechanisms.2,3 Positron emission tomography (PET) in
combination with 18F-labeled α-amino acids (Figure 1) has
been used for the non-invasive generation of molecular,
functional, and metabolic information for a wide range of
diseases.4 Although most applications have focused on imaging
various forms of cancer, compounds such as 6-[18F]fluoro-L-
DOPA have been used to investigate neurodegenerative
disorders, including Parkinson’s disease.5 The cis and trans
isomers of 4-[18F]fluoro-L-proline, [18F]1 and [18F]2, respec-
tively, have also been used to image a number of disease
conditions. Proline and 4-hydroxyproline are major structural
components of collagen (15−30%), and therefore, [18F]1 and
[18F]2 have been used to investigate abnormal collagen
biosynthesis in diseases such as liver cirrhosis, lung fibrosis,
and various carcinomas.4,6,7
Due to the importance of cis- and trans-4-[18F]fluoro-L-
proline ([18F]1 and [18F]2, respectively), several methods for
the radiosynthesis of these compounds have been developed.4c
The most common approach involves the reaction of 4-
sulfonyloxy-L-proline derivatives with [18F]fluoride, leading to
fluorination with inversion of configuration (Scheme 1a).
Development of the fluorination step by automation has
resulted in fast and efficient reactions, while formation of the
undesired diastereomer (usually as a minor product) can be
controlled by reaction temperature and removed by HPLC at
the end of the process.8 The limitations of these approaches
occur during the deprotection stage, which due to harsh
conditions is performed manually. For example, removal of the
Boc-protecting group and hydrolysis of the ester were done as
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Figure 1. Selected examples of 18F-fluorinated α-amino acids.
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a single step but required the use of triflic acid at 100−130
°C.7a−c Deprotection has also been done using a two-step
strategy involving acid-mediated removal of the Boc group (0.1
M HCl, 120 °C), followed by hydrolysis of the methyl ester
using sodium hydroxide.7b In addition to requiring an extra
step, alkaline hydrolysis of proline esters is known to produce
side products, resulting in a decrease in the radiochemical yield
(RCY).7a
For one of our imaging programs, we required access to cis-
and trans-4-[18F]fluoro-L-proline ([18F]1 and [18F]2, respec-
tively) as well as the nonradioactive analogues as standards for
radiochemistry studies. Due to the limitations of previous
approaches, we sought to develop a fully automated synthesis
involving both a nucleophilic radiofluorination reaction and a
single-step deprotection process. We now report the non-
radioactive synthesis of both cis- and trans-4-fluoro-L-proline (1
and 2, respectively) from readily available (2S,4R)-N-Boc-4-
hydroxy-L-proline, using a deoxyfluorination reaction with
morpholinosulfur trifluoride as the key step. Also described is a
fully automated synthesis of [18F]1 and [18F]2, which
combines a highly effective nucleophilic radiofluorination
with a single-step deprotection (Scheme 1b).
■ RESULTS AND DISCUSSION
Our primary aim during this project was the design and
synthesis of proline derivatives that would undergo clean and
efficient nucleophilic fluorination reactions and that could be
deprotected in a single step, under mild conditions. Previous
syntheses of 4-fluoroprolines have generally used an N-
protected derivative of 4-hydroxyproline methyl ester as the
starting material.9,10 However, issues were reported during the
nucleophilic fluorination step involving intramolecular partic-
ipation of the ester carbonyl, which led to the formation of a
fluoroproline byproduct (17%) with retention of configura-
tion.11 In this project, it was proposed that the use of a more
bulky proline derivative, such as N-Boc-L-proline tert-butyl
ester 5, would minimize any intramolecular reactions during
the fluorination step. Furthermore, the use of two acid-
sensitive protecting groups would allow rapid and mild
deprotection during the preparation of the 18F-labeled targets.
Our synthesis of cis-4-fluoro-L-proline (1) began with the
esterification of commercially available (2S,4R)-N-Boc-4-
hydroxy-L-proline (4) with O-tert-butyl-N,N-diisopropylisourea
(Scheme 2).12 This gave tert-butyl ester 5 in 68% yield. A
precursor for radiofluorination studies and the synthesis of cis-
4-[18F]fluoro-L-proline [18F]1 was prepared by tosylation of 5
under standard conditions. An initial attempt to complete the
synthesis of cis-4-fluoro-L-proline (1) investigated the
nucleophilic fluorination of tosyl derivative 6 using TBAF.10d
However, this led to elimination of tosic acid and the isolation
of dehydroproline derivatives. Instead, (2S,4R)-hydroxy-L-
proline derivative 5 was treated with morpholinosulfur
trifluoride, and this allowed the single-step synthesis of 7 in
63% yield. Analysis of the 1H NMR spectrum of the crude
reaction material showed the presence of only the cis
diastereomer, confirming complete inversion of configuration.
This result suggests that the sterically encumbered tert-butyl
ester prevents any intramolecular participation of the carbonyl
and the formation of the undesired fluorinated trans
diastereomer.13 Acid-mediated deprotection of 7 using 2 M
hydrochloric acid at room temperature gave after recrystalliza-
tion cis-4-fluoro-L-proline (1) in 64% yield.
To access trans-4-fluoro-L-proline (2) using the same
approach required the preparation of (2S,4S)-N-Boc-4-
hydroxy-L-proline (9). As (2S,4R)-N-Boc-4-hydroxy-L-proline
(4) is readily available and inexpensive, we investigated a
strategy for inversion of configuration of the 4-hydroxyl group.
Previous methods have activated the 4R-hydroxyl group of
(2S,4R)-4-hydroxy-L-proline ester derivatives by mesylation or
using a Mitsunobu reaction, followed by inversion with
benzoic acid and then hydrolysis of the resulting ester.10c−f
Raines and co-workers described a three-step approach
involving hydroxyl group mesylation, inversion by intra-
molecular lactonization with the α-carboxylic acid, and then
lactone hydrolysis.10d Inspired by this, we developed a two-step
approach in which lactone 8 was initially prepared by an
intramolecular Mitsunobu reaction of (2S,4R)-N-Boc-4-
hydroxy-L-proline (4) (Scheme 3).14 Lactone 8 was then
hydrolyzed at room temperature with lithium hydroxide to give
(2S,4S)-N-Boc-4-hydroxy-L-proline (9) in 71% yield over the
two steps. This approach was scalable, allowing the multigram
synthesis of 9. With the (2S,4S)-diastereomer 9 in hand, the
Scheme 1. Synthesis of cis-4-[18F]Fluoro-L-proline
Scheme 2. Synthesis of Precursor 6 and cis-4-Fluoro-L-
proline (1)
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same series of steps (tert-butyl esterification and tosylation)
was used to access precursor 11. Similarly, reaction of 10 with
morpholinosulfur trifluoride gave 4-fluoroproline 12 as a single
diastereomer, and deprotection under mild acidic conditions
gave trans-4-fluoro-L-proline (2) in good overall yield.
The radiosynthesis of [18F]1 and [18F]2 using a TRACERlab
FXFN automated synthesizer and precursors 6 and 11 was next
investigated. During these experiments, no-carrier-added
[18F]fluoride from the cyclotron was trapped on a carbonate-
preconditioned quaternary methylammonium (QMA) car-
tridge, eluted into the reactor with a solution containing K222/
K2CO3, and then azeotropically dried. To compare the
effectiveness of precursors 6 and 11 with previous methods,
[18F]fluoride was reacted initially with commercially available
(2S,4R)-proline methyl ester derivative 3 under literature
conditions (Scheme 4). This involved reaction with [18F]-
fluoride at 110 °C for 10 min, followed by deprotection with 2
M triflic acid at 127 °C for 10 min.7a,c,8 Although radio-HPLC
analysis showed high conversion to cis isomer [18F]1 (84.56%),
trans isomer [18F]2 (4.59%) and unreacted [18F]fluoride
(10.85%) were also detected.15 In addition, multiple runs on
the synthesizer using triflic acid caused damage to tubing and
values, resulting in leaks and failed syntheses.
Similar conditions for radiofluorination and subsequent
deprotection of (2S,4R)-proline tert-butyl ester derivative 6
were then investigated (Table 1, entry 1). To ensure complete
conversion of [18F]fluoride, a longer radiofluorination reaction
time of 15 min was used. In addition, triflic acid was replaced
with 2 M hydrochloric acid during the deprotection stage.
Following a total reaction time of 74 min, this gave [18F]1 in a
decay-corrected RCY of 42%. A benefit of a slightly longer
radiofluorination reaction time was that less precursor was
required for complete conversion of [18F]fluoride. With
precursor 6, the amount for each run could be reduced from
16 to 5 mg. The study next investigated the use of milder
conditions to remove the acid-labile protecting groups.
Radiofluorination of 6, followed by deprotection with 2 M
hydrochloric acid at 60 °C, gave [18F]1 in 19% RCY (entry 2).
It was proposed that the lower RCY for this production was
partly due to the use of a strong cation exchange (SCX)
cartridge during the final formulation stage. Therefore, the
two-step process was repeated using both a shorter reaction
time (5 min) for the deprotection step and a mixed-mode
cation exchange (MCX) cartridge during the formulation
(entry 3). This gave a 42% RCY of [18F]1 after a total reaction
time of 71 min. Further optimization was achieved by avoiding
an evaporation stage after initial radiofluorination (entry 4).
This resulted in a shorter overall reaction time of 63 min and
gave [18F]1 in 36% RCY. The corresponding radio-HPLC
chromatogram under these optimized conditions showed clean
synthesis of [18F]1 (Figure 2). The reaction mixture was found
to contain 98.8% [18F]1, with <0.4% trans isomer [18F]2.15,16
The optimized conditions were then used for the automated
production, isolation, and purification of [18F]1 (Scheme 5).
After a total synthesis time of 59 min, this gave [18F]1 in 41 ±
3.6% RCY (n = 9) with a >99% radiochemical purity. The
molar activity of [18F]1 was found to be >0.641 GBq μmol−1.17
The optimized conditions were then used for the automated
synthesis of [18F]2 using precursor 11. In a similar manner, the
two-step process was found to be highly selective for the
preparation of [18F]2, generating the trans isomer in 97.7%
yield, with 2.2% of the cis isomer also observed.15 Use of this
method for the automated production and purification of [18F]
2 gave the target after a total synthesis time of 57 min, in 34 ±
4.3% RCY (n = 11) with a >99% radiochemical purity. The
molar activity of [18F]2 was found to be >0.320 GBq μmol−1.17
The stability of formulated products [18F]1 and [18F]2 using
radio-HPLC was analyzed at 2 and 11 h points from the end of
synthesis.15 For both isomers, there was no observed
radiochemical byproduct after 11 h, which confirmed that
these imaging agents are stable within this time frame to
decomposition pathways, such as epimerization or radiolysis.
Scheme 3. Synthesis of Precursor 11 and trans-4-Fluoro-L-
proline (2)
Scheme 4. Automated Radiosynthesis of cis-4-[18F]Fluoro-L-
proline [18F]1 using Precursor 3











1 127 °C, 10 min SCX 74 42
2 60 °C, 10 min SCX 66 19
3 60 °C, 5 min MCX 71 42
4b 60 °C, 5 min MCX 63 36
aDecay-corrected RCYs are presented. bEvaporation was not
performed after the fluorination step.
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■ CONCLUSIONS
In summary, a new approach for the preparation of cis-4-
fluoro-L-proline (1) has been developed from (2S,4R)-N-Boc-
4-hydroxy-L-proline (4). The use of a sterically hindered tert-
butyl derivative during the key fluorination step with
morpholinosulfur trifluoride prevented any intramolecular
side reactions, yielding a single diastereomer as the sole
product. Following preparation of (2S,4S)-N-Boc-4-hydroxy-L-
proline (9) from commercially available (2S,4R)-diastereomer
4 via an intramolecular Mitsunobu reaction and lactone
hydrolysis, a similar approach was developed for the
preparation of trans-4-fluoro-L-proline (2). The tosylated
derivatives were then investigated as substrates for a fully
automated synthesis of cis- and trans-4-[18F]fluoro-L-proline
([18F]1 and [18F]2, respectively). The bulky precursors
underwent clean and reproducible radiofluorination, and the
use of two acid-sensitive protecting groups allowed depro-
tection under mild conditions. It should be noted that both
steps are highly amenable to automation when using a
synthesizer and, thus, avoid typically harsh conditions and
manual handling of radioactive intermediates.
■ EXPERIMENTAL SECTION
All reagents and starting materials were obtained from commercial
sources and used as received unless otherwise stated. Dry solvents
were purified using a solvent purification system. Brine refers to a
saturated solution of sodium chloride. All reactions were performed in
oven-dried glassware under an atmosphere of argon unless otherwise
stated. All mixtures for reactions performed at increased temperatures
were heated using an oil bath. Flash column chromatography was
carried out using silica gel (40−63 μm). Aluminum-backed plates
precoated with silica gel 60 (UV254) were used for thin layer
chromatography and visualized under ultraviolet light and by staining
with KMnO4, ninhydrin, or vanillin.
1H NMR spectra were recorded
on an NMR spectrometer at 400 or 500 MHz, and data are reported
as follows: chemical shift in parts per million relative to
tetramethylsilane or the solvent as the internal standard (CDCl3, δ
7.26), multiplicity (s, singlet; d, doublet; t, triplet; q, quartet; m,
multiplet or overlap of nonequivalent resonances, integration).
13C{1H} NMR spectra were recorded on an NMR spectrometer at
101 or 126 MHz, and data are reported as follows: chemical shift in
parts per million relative to tetramethylsilane or the solvent as the
internal standard (CDCl3, δ 77.0), multiplicity with respect to
hydrogen (deduced from DEPT experiments, C, CH, CH2, or CH3).
IR spectra were recorded on a FTIR spectrometer; wavenumbers are
indicated in inverse centimeters. Mass spectra were recorded using
electron impact or electrospray ionization techniques. HRMS spectra
were recorded using a dual-focusing magnetic analyzer mass
spectrometer. Melting points are uncorrected. Optical rotations
were determined as solutions irradiating with the sodium D line (λ




late (5).18 To a solution of N-(tert-butoxycarbonyl)-(2S,4R)-4-
Figure 2. Radio-HPLC chromatogram of the reaction mixture (black). An overlay of the UV/vis HPLC trace of trans-4-fluoro-L-proline (2) (blue)
and cis-4-fluoro-L-proline (1) (red) is also shown.
Scheme 5. Automated Radiosynthesis of cis- and trans-4-
[18F]Fluoro-L-proline ([18F]1 and [18F]2, respectively)a
aDecay-corrected RCYs are presented.
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hydroxypyrrolidine-2-carboxylic acid (4) (0.500 g, 2.16 mmol) in dry
tetrahydrofuran (2.5 mL), under argon at 0 °C was added tert-butyl
N,N′-diisopropylcarbamimidate (0.500 mL, 2.16 mmol). The reaction
mixture was heated to 70 °C for 3 h, followed by further addition of
tert-butyl N,N′-diisopropylcarbamimidate (0.500 mL, 2.16 mmol).
The reaction mixture was heated for a further 18 h. The reaction
mixture was filtered through Celite and then concentrated in vacuo.
Purification by flash column chromatography eluting with 50% ethyl
acetate in hexane gave di-tert-butyl (2S,4R)-4-hydroxypyrrolidine-1,2-
dicarboxylate (5) as a white solid (0.420 g, 68%): [α]D
14 −55.3 (c 0.2,
CHCl3) [lit.
18 [α]D
25 −51.3 (c 1.3, CHCl3)]. Spectroscopic data
matched the literature.18
Di-tert-butyl (2S,4R)-4-(Tosyloxy)pyrrolidine-1,2-dicarboxy-
late (6).19 To a solution of di-tert-butyl (2S,4R)-4-hydroxypyrroli-
dine-1,2-dicarboxylate (5) (1.50 g, 5.22 mmol) in dichloromethane
(30 mL) at 0 °C were added pyridine (0.840 mL, 10.4 mmol), 4-
dimethylaminopyridine (0.0640 g, 0.520 mmol), and p-toluenesul-
fonyl chloride (1.99 g, 10.4 mmol). The reaction mixture was heated
to 40 °C for 96 h and then concentrated in vacuo. Purification by flash
column chromatography eluting with 20% ethyl acetate in hexane
gave di-tert-butyl (2S,4R)-4-(tosyloxy)pyrrolidine-1,2-dicarboxylate
(6) as a white solid (1.90 g, 81%): [α]D
17 −27.0 (c 0.1, CHCl3).
Spectroscopic data matched the literature.19
Di-tert-butyl (2S,4S)-4-Fluoropyrrolidine-1,2-dicarboxylate
(7). To a solution of di-tert-butyl (2S,4R)-4-hydroxypyrrolidine-1,2-
dicarboxylate (5) (0.150 g, 0.522 mmol) in dry dichloromethane (3
mL), under argon, was added dropwise morpholinosulfur trifluoride
(0.330 mL, 2.61 mmol). The reaction mixture was stirred at room
temperature for 48 h and concentrated in vacuo, and water (20 mL)
was added to the resulting residue. The aqueous layer was extracted
with ethyl acetate (3 × 10 mL), and the combined extracts were then
washed with water (3 × 10 mL) and sodium bicarbonate (3 × 10
mL), dried over MgSO4, filtered, and concentrated in vacuo.
Purification by flash column chromatography eluting with 30% ethyl
acetate in hexane gave di-tert-butyl (2S,4S)-4-fluoropyrrolidine-1,2-
dicarboxylate (7) as a colorless oil (0.092 g, 63%): IR (neat) 2976,
1736, 1701, 1395, 1366, 1151, 1117, 1070, 769 cm−1; [α]D
15 −33.3 (c
0.2, CHCl3); NMR spectra showed a 2:1 mixture of rotamers. Only
data for the major rotamer were recorded: 1H NMR (500 MHz,
CDCl3) δ 5.18 (dt, J = 53.0, 4.2 Hz, 1H), 4.29 (d, J = 9.3 Hz, 1H),
3.79 (dt, J = 27.0, 13.0 Hz, 1H), 3.73−3.57 (m, 1H), 2.51−2.20 (m,
2H), 1.48 (s, 9H), 1.45 (s, 9H); 13C{1H} NMR (126 MHz, CDCl3) δ
170.8 (C), 153.8 (C), 91.2 (d, 1JC−F = 177.3 Hz, CH), 81.4 (C), 80.1
(C), 58.4 (CH), 53.0 (d, 2JC−F = 24.6 Hz, CH2), 37.7 (d,
2JC−F = 22.0
Hz, CH2), 28.3 (3 × CH3), 27.9 (3 × CH3); MS (ESI) m/z 312 (M +
Na+, 100); HRMS (ESI) m/z [M + Na]+ calcd for C14H24FNNaO4
312.1582, found 312.1579.
(2S,4S)-4-Fluoropyrrolidine-2-carboxylic Acid Hydrochlor-
ide (1). To a solution of di-tert-butyl (2S,4S)-4-fluoropyrrolidine-1,2-
dicarboxylate (7) (0.0500 g, 0.170 mmol) in acetonitrile (0.2 mL)
was added 2 M hydrochloric acid (2 mL). The reaction mixture was
stirred at room temperature for 5 h and then concentrated in vacuo.
Purification by trituration with chloroform yielded (2S,4S)-4-
fluoropyrrolidine-2-carboxylic acid hydrochloride (1) as a white
solid (0.0180 g, 64%): mp 130−136 °C dec; IR (neat) 3358, 2947,
1742, 1717, 1603, 1499, 1263, 1246, 1179, 1026 cm−1; [α]D
15 −13.9
(c 0.1, MeOH); 1H NMR (500 MHz, CD3OD) δ 5.44 (dt, J = 52.1,
3.6 Hz, 1H), 4.65−4.59 (m, 1H), 3.74 (ddd, J = 20.0, 13.5, 1.5 Hz,
1H), 3.56 (ddd, J = 35.7, 13.5, 3.6 Hz, 1H), 2.78−2.58 (m, 2H);
13C{1H} NMR (126 MHz, CD3OD) δ 169.5 (C), 91.5 (d,
1JC−F =
177.2 Hz, CH), 58.2 (CH), 52.0 (d, 2JC−F = 24.0 Hz, CH2), 35.4 (d,
2JC−F = 22.0 Hz, CH2); MS (ESI) m/z 134 (M + H
+, 100); HRMS
(ESI) m/z [M + H]+ calcd for C5H9FNO2 134.0612, found 134.0611.
tert-Butyl (1S,4S)-2-Oxa-3-oxo-5-azabicyclo[2.2.1]heptane-
5-carboxylate (8).20 To a solution of N-(tert-butoxycarbonyl)-
(2S,4R)-4-hydroxypyrrolidine-2-carboxylic acid (4) (6.00 g, 26.0
mmol) in dry tetrahydrofuran (200 mL) under argon at 0 °C was
added triphenylphosphine (8.17 g, 31.1 mmol), followed by dropwise
addition of diisopropyl azodicarboxylate (6.13 mL, 31.1 mmol). The
reaction mixture was stirred at room temperature for 18 h and
concentrated in vacuo. Purification by column chromatography eluting
with 80% diethyl ether in hexane gave tert-butyl (1S,4S)-2-oxa-3-oxo-
5-azabicyclo[2.2.1]heptane-5-carboxylate (8) as a white solid (4.30 g,
77%): [α]D
19 +43.8 (c 1.0, CHCl3) [lit.
20 [α]D
20 +46.3 (c 1.0,
CHCl3)]. Spectroscopic data matched the literature.
20
N-(tert-Butoxycarbonyl)-(2S,4S)-4-hydroxypyrrolidine-2-
carboxylic Acid (9).21 To a solution of tert-butyl (1S,4S)-2-oxa-3-
oxo-5-azabicyclo[2.2.1]heptane-5-carboxylate (8) (4.00 g, 18.8
mmol) in a mixture of water (60 mL), tetrahydrofuran (40 mL),
and methanol (40 mL) was added lithium hydroxide monohydrate
(2.36 g, 56.3 mmol). The reaction mixture was stirred at room
temperature for 18 h and concentrated in vacuo, and ethyl acetate
(100 mL) was added to the oily residue. The solution was acidified
using a saturated aqueous solution of potassium hydrogen sulfate, and
the aqueous layer extracted with ethyl acetate (3 × 150 mL). The
combined extracts were dried over MgSO4 and concentrated in vacuo
to give N-(tert-butoxycarbonyl)-(2S,4S)-4-hydroxypyrrolidine-2-car-
boxylic acid (9) as a white solid (4.00 g, 92%): [α]D
21 −38.5 (c 0.3,
MeOH) [lit.21 [α]D −39.0 (c 0.7, MeOH)]. Spectroscopic data
matched the literature.21
Di-tert-butyl (2S,4S)-4-Hydroxypyrrolidine-1,2-dicarboxy-
late (10).22 Di-tert-butyl (2S,4S)-4-hydroxypyrrolidine-1,2-dicarbox-
ylate (10) was prepared as described for di-tert-butyl (2S,4R)-4-
hydroxypyrrolidine-1,2-dicarboxylate (5) using N-(tert-butoxycarbon-
yl)-(2S,4S)-4-hydroxypyrrolidine-2-carboxylic acid (9) (1.00 g, 4.32
mmol), dry tetrahydrofuran (5.0 mL), and tert-butyl N,N′-
diisopropylcarbamimidate (0.965 mL, 4.33 mmol), followed by
further addition of tert-butyl N,N′-diisopropylcarbamimidate (0.965
mL, 4.33 mmol) after 3 h. Purification by column chromatography
eluting with 40% ethyl acetate in hexane gave di-tert-butyl (2S,4S)-4-
hydroxypyrrolidine-1,2-dicarboxylate (10) as a white solid (0.650 g,
87%): [α]D
20 −7.0 (c 0.1, CHCl3). Spectroscopic data matched the
literature.22
Di-tert-butyl (2S,4S)-4-(Tosyloxy)pyrrolidine-1,2-dicarboxy-
late (11).22 Di-tert-butyl (2S,4S)-4-(tosyloxy)pyrrolidine-1,2-dicar-
boxylate (11) was prepared as described for di-tert-butyl (2S,4R)-4-
(tosyloxy)pyrrolidine-1,2-dicarboxylate (6) using di-tert-butyl
(2S,4S)-4-hydroxypyrrolidine-1,2-dicarboxylate (10) (0.500 g, 1.74
mmol), dry dichloromethane (10 mL), pyridine (0.280 mL, 3.48
mmol), 4-dimethylaminopyridine (0.0210 g, 0.174 mmol), and p-
toluenesulfonyl chloride (0.663 g, 3.48 mmol). The reaction mixture
was heated for 48 h. Purification by column chromatography eluting
with 20% ethyl acetate in hexane gave di-tert-butyl (2S,4S)-4-
(tosyloxy)pyrrolidine-1,2-dicarboxylate (11) as a white solid (0.500
g, 66%): [α]D
20 −25.4 (c 0.5, CHCl3) [lit.22 [α]D34 −28.3 (c 0.5,




(12) was prepared as described for di-tert-butyl (2S,4S)-4-
fluoropyrrolidine-1,2-dicarboxylate (7) using di-tert-butyl (2S,4S)-4-
hydroxypyrrolidine-1,2-dicarboxylate (10) (0.150 g, 0.522 mmol), dry
dichloromethane (3 mL), and morpholinosulfur trifluoride (0.330
mL, 2.61 mmol). Purification by column chromatography eluting with
20% ethyl acetate in hexane gave di-tert-butyl (2S,4R)-4-fluoropyrro-
lidine-1,2-dicarboxylate (12) as a colorless oil (0.084 g, 57%): IR
(neat) 2978, 1744, 1703, 1398, 1368, 1152 cm−1; [α]D
20 −8.8 (c 0.2,
CHCl3). NMR spectra showed a 2:1 mixture of rotamers; only data
for the major rotamer were recorded: 1H NMR (400 MHz, CDCl3) δ
5.16 (dt, J = 52.6, 3.0 Hz, 1H), 4.26 (t, J = 8.3 Hz, 1H), 3.89 (ddd, J =
21.8, 13.0, 3.0 Hz, 1H), 3.55 (ddd, J = 36.1, 13.0, 3.0 Hz, 1H), 2.64−
2.44 (m, 1H), 2.14−1.92 (m, 1H), 1.44 (s, 9H), 1.42 (s, 9H);
13C{1H} NMR (101 MHz, CDCl3) δ 171.7 (C), 153.8 (C), 91.0 (d,
1JC−F = 178.7 Hz, CH), 81.4 (C), 80.4 (C), 58.2 (CH), 53.0 (d,
2JC−F
= 22.8 Hz, CH2), 37.6 (d,
2JC−F = 22.8 Hz, CH2), 28.3 (3 × CH3),
28.0 (3 × CH3); MS (ESI) m/z 312 (M + Na+, 100); HRMS (ESI)
m/z [M + Na]+ calcd for C14H24FNNaO4 312.1582, found 312.1580.
(2S,4R)-4-Fluoropyrrolidine-2-carboxylic Acid Hydrochlor-
ide (2). (2S,4R)-4-Fluoropyrrolidine-2-carboxylic acid hydrochloride
(2) was prepared as described for (2S,4S)-4-fluoropyrrolidine-2-
carboxylic acid hydrochloride (1) using di-tert-butyl (2S,4R)-4-
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fluoropyrrolidine-1,2-dicarboxylate (12) (0.0800 g, 0.280 mmol),
acetonitrile (0.25 mL), and 2 M hydrochloric acid (2.5 mL). This
gave (2S,4S)-4-fluoropyrrolidine-2-carboxylic acid hydrochloride (2)
as an off-white solid (0.0331 g, 70%): mp 148−152 °C dec; IR (neat)
3672, 2987, 1738, 1682, 1406, 1242, 1220, 1067, 1051 cm−1; [α]D
17
−6.5 (c 0.1, MeOH); 1H NMR (400 MHz, CD3OD) δ 5.47 (dt, J =
51.8, 3.6 Hz, 1H), 4.61 (dd, J = 10.5, 7.9 Hz, 1H), 3.73−3.52 (m,
2H), 2.84−2.70 (m, 1H), 2.39 (dddd, J = 38.5, 14.8, 10.5, 3.6 Hz,
1H); 13C{1H} NMR (101 MHz, CD3OD) δ 169.3 (C), 92.0 (d,
1JC−F
= 177.0 Hz, CH), 58.0 (CH), 51.7 (d, 2JC−F = 24.0 Hz, CH2), 35.4 (d,
2JC−F = 22.1 Hz, CH2); MS (ESI) m/z 134 (M + H
+, 100); HRMS
(ESI) m/z [M + H]+ calcd for C5H9FNO2 134.0612, found 134.0613.
Radiochemistry: General Experimental. No-carrier-added
aqueous [18F]fluoride was produced via the 18O(p,n)18F nuclear
reaction by irradiation of 18O-enriched water by a GE PETtrace 8
cyclotron. All radiofluorination reactions were carried out on a GE
TRACERlab FXFN automated synthesizer. Sep-Pak QMA Carbonate
Plus Light cartridges (Waters) were preconditioned with water (10
mL) prior to use. Oasis MCX Plus Short (Waters) and Bond Elut
SCX 1 g (Agilent) cartridges were preconditioned with ethanol (5
mL) and then with water (10 mL) prior to use. The starting activity
for calculating the radiochemical yield was determined from the GM
reading taken immediately following delivery of [18F]fluoride to the
synthesizer from the cyclotron. The final activity readings were
recorded using a Capintec CRC-25 PET dose calibrator.
Analytical HPLC Method. Analytical HPLC was carried out on a
Thermo Dionex Ulimate system 3000 equipped with a Berthold
FlowStar LB 513 radio flow detector and a DAD-3000 UV detector.
An isocratic mobile phase of 60% acetonitrile in water was used with a
Phenomenex Luna 5 μm NH2 100 Å, 250 mm × 4.6 mm column at a
rate of 1 mL min−1. The nonradioactive standards were detected using
a UV wavelength of 210 nm.
cis-4-[18F]Fluoro-L-proline [18F]1. Cyclotron target water con-
taining [18F]fluoride was transferred to and trapped on a Sep-Pak
QMA Carbonate Plus Light cartridge. The activity was eluted into a
reaction vessel using a solution of Kryptofix 222 (15 mg) and
potassium carbonate (2.4 mg) in acetonitrile (0.80 mL) and water
(0.40 mL). This solution was dried by being stirred at 100 °C under
vacuum and a stream of helium gas for 2 min. This process was
repeated twice using acetonitrile (2 × 1 mL). The [18F]fluoride was
then completely dried by applying full vacuum for 1 min. Di-tert-butyl
(2S,4R)-4-(tosyloxy)pyrrolidine-1,2-dicarboxylate (6) (5.0 mg) in
acetonitrile (1.0 mL) was added to the reaction vessel, which was
sealed, and the mixture heated to 110 °C for 15 min while being
stirred. The reaction mixture was then cooled to 60 °C, and a 4 M
aqueous solution of hydrochloric acid (1.0 mL) was added (resulting
in a 2 M concentration of hydrochloric acid). The reaction mixture
was stirred at this temperature for 5 min and then concentrated by
applying vacuum under a stream of helium gas. The resultant residue
was then cooled to 30 °C and diluted with a 50% aqueous solution of
acetonitrile (2.0 mL). The reaction mixture was then transferred into
the HPLC injector loop for purification. Purification was performed
by semipreparative HPLC with a SYKMN S1122 solvent delivery
system using a Phenomenex Luna 5 μm NH2 100 Å, 250 mm × 10
mm column and eluted using a 60% aqueous solution of acetonitrile
at a flow rate of 4 mL min−1. The product fraction was identified using
a gamma detector at a retention time of approximately 9 min and
collected into a flask containing an aqueous solution (20 mL)
adjusted to pH 3 using phosphoric acid. The diluted fraction was then
passed onto an Oasis MCX Plus Short cartridge, washed with water
(10 mL), and eluted from the cartridge with a 0.1 M aqueous solution
of sodium phosphate (6.0 mL). The formulation was then adjusted to
pH 7 by the addition of a 1 M aqueous solution of hydrochloric acid
(0.5 mL). cis-4-[18F]Fluoro-L-proline [18F]1 was isolated in 41 ± 3.6%
radiochemical yield with a radiochemical purity of >99% (n = 9). The
total synthesis time from delivery of [18F]fluoride to extraction of the
product was 59 ± 1.9 min.
trans-4-[18F]Fluoro-L-proline [18F]2. The reaction was carried
out according to the same general procedure as that for cis-4-
[18F]fluoro-L-proline [18F]1 using di-tert-butyl (2S,4S)-4-(tosyloxy)-
pyrrolidine-1,2-dicarboxylate (11) (5.0 mg) in acetonitrile (1.0 mL).
The product fraction was identified using a gamma detector at a
retention time of approximately 7 min. trans-4-[18F]Fluoro-L-proline
[18F]2 was isolated in 34 ± 4.3% radiochemical yield with a
radiochemical purity of >99% (n = 11). The total synthesis time from
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